Incorporated in 2007, Eris Lifesciences Limited is a full integrated Pharmaceutical company. The company is a leading manufacturer of chronic category and acute category. The company is second fastest growing in Chronic therapy segment. Company is focused on formulations market of cardiovascular; anti-diabetes; vitamins; gastroenterology and gynecology.
July 4th, 2019:Eris Lifesciences Limited (BSE:540596 | NSE:ERIS) board has approved a proposal for purchase of up to 17.39 lakh(Seventeen lakhs and thirty nine thousand) shares at Rs 575 (Five hundred seventy five) per share, aggregating Rs 100 Cr(one hundred crore) (Buyback Offer Size) that is 1.26% of total paid- up equity capital of the Company.
»» Total Share Capital: Rs 6,822.36 Cr
»» Face Value: 1 Per Equity Share
»» Buyback Offer Amount: Rs 100 Cr
»» Buyback Offer Size (In %): 1.26%
»» Buyback Number of Shares: 17.39 Lakhs
»» Buyback Price: Rs 575
»» Promoters and Promoter Group participation:Yes
»» Buyback type:Tender Offer
»» Can I Invest today to participate in Eris Lifesciences Limited buyback offer :No
We advocate honest for Eris Lifesciences buyback as official acceptance ratio for the retail investors are going to be between 15 to 20% (Fifteen to Twenty percent) and actual acceptance ration is going to be thirty to sixty percent (30% to 60%). We tend to rate Eris Lifesciences buyback as 3.5/5 (Average).
Making a resonable amount of profit is possible in Eris Lifesciences buyback for a new retail investor. Buyback price is up by 15% from current market price.
As per March 2019 shareholding approx 15,00,000 shares are hold by retail investors, number of shares blocked for retail share holders are 2.60 lakhs. So in that approx buyback acceptance ration is going to above 15%.
In this section we have covered all imporatant dates related to Eris Lifesciences Limited Buyback. Dates are updated as they are announced. The most noted dates are record date and buyback open and close dates, which one should use to participate in buyback.
|Board Meeting for Buyback proposal||3rd Jul 2019|
|Buyback Approval date||3rd Jul 2019|
|Public Announcement of Buyback||4th Jul 2019|
|Record Date||15th Jul 2019|
|Buyback opens on/Buyback Opening Date||1st Jan 2020|
|Buyback closes on/Buyback Closing Date||14th Jan 2020|
|Cut-off date to receive completed tender forms by Registrar||22nd Jan 2020|
|Cut-off date for verification by the Registrar||22nd Jan 2020|
|Cut-off date to inform Stock Exchange on acceptance or non-acceptance of tendered Equity Shares by Registrar||22nd Jan 2020|
|Last date of settlement of bids on the stock exchange||23rd Jan 2020|
|Last date to return unaccepted shares by Registrar||23rd Jan 2020|
|Last date of extinguishment of Equity Shares||30th Jan 2020|
Stock Holding table will give you a clear picture, how many retail investor holding Eris Lifesciences Limited shares, with this you can plan for participate in buyback offer. The less number of retail holding make more chance to get higher acceptance ratio in buyback under ratail category = higher profit.
|Holding Type||In %|
Eris Lifesciences Limited Draft Letter of Offer >>Document
Eris Lifesciences Limited Letter of Offer >>Document
Eris Lifesciences Limited Post Buyback Public Announcement >>Document
For Buy back shares holders are divided in 2 categories:
|Category||Entitlement Ratio of Buyback Per Equity Shares||Entitlement Ratio of Buyback in %|
|Reserved Category||50 Equity Share out of every 231 fully paid-up Equity Share held on the Record Date.||21.65|
|General Category||5 Equity Share out of every 461 fully paid-up Equity Share held on the Record Date.||1.08%|
For Eris Lifesciences Limited Buyback Offer, Report updated by the manager of buyback -
In general category - response received 504.57%, No. of Equity Shares reserved in Buyback was 1478260 where valid bid received for retail category was 7458837 which is 504.57% oversubscribed.
In Reserved category for Small Shareholders (Retail) - response received only 160.71%, No. of Equity Shares reserved in Buyback was 260870 where valid bid received for retail category was 419246 which is 160.71%. Final Acceptance Ratio for Retail Investors was 20%.
The table below will give you a complete dashboard view for all open buyback offer in current market.
|Company Name||Buyback Type||Offer Amount||Buyback Price||CMP||Record Date||Buyback Open Date||Buyback End Date|
|Thomas Cook India Ltd||Tender Offer||Rs 150 Cr||57.50||24.60 (4.46%)||07-03-2020||TBD||TBD||NIIT Technologies||Tender Offer||Rs 337 Cr||1725||1505.50 (4.37%)||12-03-2020||TBD||TBD||Tips Industries Limited||Tender Offer||Rs 18.90 Cr||140||96.25 (-1.58%)||03-04-2020||TBD||TBD||Coral India Finance And Housing Ltd||Tender Offer||Rs 21.08 Cr||17||13.50 (-2.46%)||17-04-2020||TBD||TBD||Indiabulls Real Estate Limited||Tender Offer||Rs 500 Cr||100||41.10 (1.36%)||TBD||TBD||TBD||Granules India Ltd||Tender Offer||Rs 250 Cr||200||165.75 (-1.54%)||TBD||TBD||TBD|
Do you know you could reduce the brokerage cost significantly by moving to another stock broker? Our expert team compare top share brokers in India to help investors like you. STOP paying Demat AMC, brokerage in %, PCM fee and high stamp duty today.
We can help you choose the right broker. Contact us today...
Detail Article on Benefit from buyback offer >> ReadEris Lifesciences Limited Buyback Important dates - Record Date,Buyback Start and End date. Buyback Details - Buyback Price, Buyback Offer Size, Buyback Number of Shares, Retail Investors limit. What is the record date for Eris Lifesciences Limited ? How can I apply in Eris Lifesciences Limited Buyback offer?
Last Updated on 2020-01-29T00:12:29+00:00
The Record Date for Eris Lifesciences Limited Buyback offer is 15th Jul 2019
Which means you should hold the Eris Lifesciences Limited share in your demat account by closing session of 15th Jul 2019. Share purchased on and before (15th Jul 2019) - 2 business days will be available in your demat account by 15th Jul 2019.
Its all depend on acceptance ratio which usually announce with Letter of Offer. Lets assume if you have Eris Lifesciences Limited shares at ₹500 and buyback offer price is ₹575, you can get ₹75 per accepted share. If you hold 400 shares of Eris Lifesciences Limited and if proportionate acceptance is between 33% and 50%, in such case you are eligible to sell your 132 to 200 shares with the gain from buyback of ₹9900 to ₹15000.
The percentage of proportionate acceptance varies from company to company. This percentage can be also 100% which means that company buys all of your shares.
|% Share Accepted||No of Shared Accepted||Gain from Buyback Offer|
Steps to participate in Eris Lifesciences Limited buyback:
Share holders who hold less than 2 lakh worth of shares are consider in Retail Category. All others will consider in General Category. Last trading price on record date will be used to calculate the eligibility criteria.
Buyback opening date for Eris Lifesciences Limited : 1st Jan 2020
Buyback closing date for Eris Lifesciences Limited : 14th Jan 2020
This is the window when you need to submit your application for proposal for share buyback. If you are submitting tender forms or submitting physical share certificates, it must reach to registrar by 22nd Jan 2020.
As this is a buyback tender offer, shares are accepted in proportionate basis. Proportionate acceptance / rejection will be returned back to the eligible shareholders directly by the Registrar on or before 23rd Jan 2020.
Money will be directly deposited in your registered bank account with broker. Usually money will be deposited on and after 23rd Jan 2020, which is last date of settlement of bids on the Stock Exchange.
In case of physical share holding, you will get a cheque.